Sun BioPharma, Inc.·4

May 23, 7:28 PM ET

Horvath Susan 4

4 · Sun BioPharma, Inc. · Filed May 23, 2019

Insider Transaction Report

Form 4
Period: 2019-05-21
Horvath Susan
V.P. of Finance & CFO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-05-21+9,5009,500 total
    Exercise: $2.95From: 2019-05-21Exp: 2029-05-21Common Stock (9,500 underlying)
  • Award

    Employee Stock Option (right to buy)

    2019-05-21+48,30048,300 total
    Exercise: $2.95Exp: 2029-05-21Common Stock (48,300 underlying)
Footnotes (1)
  • [F1]Immediately exercisable as to 25% of the shares and scheduled to vest with respect to 25% of the shares on each of May 21, 2020, May 21, 2021 and May 21, 2022.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4